›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:HTG EdgeSeq Oncology Biomarker Panel (OBP)
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
HTG Molecular DiagnosticsType:
Laboratory Developed Test
Related tests:
The HTG EdgeSeq Oncology Biomarker Panel (OBP) is a systems biology pathway analysis tool that profiles samples to identify therapeutic targets and drug response markers. The OBP assay utilizes our automated HTG EdgeSeq system coupled with the sensitivity and dynamic range of next-generation sequencing (NGS)-based detection, and can be performed in your lab using the HTG EdgeSeq system.
Cancer:
Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), CD19 (CD19 Molecule), CTLA4 (Cytotoxic T-Lymphocyte Associated Protein 4), EGFR (Epidermal growth factor receptor), ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3), FGFR1 (Fibroblast growth factor receptor 1)
See More ...
AKT1 (V-akt murine thymoma viral oncogene homolog 1), CD19 (CD19 Molecule), CTLA4 (Cytotoxic T-Lymphocyte Associated Protein 4), EGFR (Epidermal growth factor receptor), ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3), FGFR1 (Fibroblast growth factor receptor 1), FGFR2 (Fibroblast growth factor receptor 2), HER-2 (Human epidermal growth factor receptor 2), MET (MET proto-oncogene, receptor tyrosine kinase), PD-1 (Programmed cell death 1), PD-L1 (Programmed death ligand 1), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), mTOR (Mechanistic target of rapamycin kinase)
Method:
Next-Generation Sequencing (NGS)
